FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Market Closed - BOERSE MUENCHEN 19:27:25 10/05/2024 BST | ||
| 5.46 EUR | +2.82% |
|
| Current month | -12.08% | ||
| 1 month | +18.18% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 5.46 | +2.82% | 0 |
| 09/05/24 | 5.31 | +3.91% | 0 |
| 08/05/24 | 5.11 | +5.58% | 0 |
| 07/05/24 | 4.84 | -5.65% | 0 |
| 06/05/24 | 5.13 | +2.40% | 0 |
Real-time BOERSE MUENCHEN
Last update May 10, 2024 at 07:27 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GG20AT |
| ISIN | DE000GG20AT7 |
| Date issued | 22/01/2024 |
| Strike | 124.3 $ |
| Maturity | Unlimited |
| Parity | 2.47 : 1 |
| Emission price | 8.42 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.6 € |
|---|---|
| Lowest since issue | 2.86 € |
| Spread | 0.3 € |
| Spread % | 5.15% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.4
USD
Average target price
146.7
USD
Spread / Average Target
+6.01%
- Stock Market
- Certificates
- Certificat
